News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
150last 24h
989last 7d
139● bullish (7d)
123● bearish (7d)
213publishers
Zacks141d agoneutral
ImmunityBio to Report Q1 Earnings: What's in the Cards?IBRX's Q1 outlook rides on Anktiva's surging uptake, with preliminary revenues showing triple-digit growth ahead of its earnings report later this month.